Join to View Full Profile
1510 S Central AveSuite 300Glendale, CA 91204
Phone+1 818-265-2255
Fax+1 818-507-5027
Dr. El-Harazi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonResidency, Ophthalmology, 1997 - 2001- University of Texas Health Science Center at HoustonInternship, Transitional Year, 1996 - 1997
University of Alexandria Faculty of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 2001 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Medflow EHR, Medflow, Inc., 2013
Clinical Trials
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain Start of enrollment: 2016 Jun 01
- Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- Sepetaprost 0.002% Non-Inferiority Versus Timolol 0.5% in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2.David L Wirta, Sherif M El-Harazi, Michael E Tepedino, Jason Bacharach
Ophthalmology. Glaucoma. 2025-03-03 - Recombinant human nerve growth factor (cenegermin) for moderate-to-severe dry eye: phase II, randomized, vehicle-controlled, dose-ranging trial.David Wirta, William Lipsky, Melissa Toyos, Joseph Martel, John Goosey
BMC Ophthalmology. 2024-07-17 - 9 citationsSafety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study.Shane Kannarr, Sherif M El-Harazi, Majid Moshirfar, Christopher Lievens, Jennifer Lee Kim
American Journal of Ophthalmology. 2023-09-01
Press Mentions
Efficacy of Verkazia to Treat Rare Eye Infection (Vernal Keratoconjunctivitis)May 12th, 2022- Santen’s Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United StatesMay 2nd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
